Global Personalized Medicine Market Reviewed & Forecast in New Topical Study Published at MarketPublishers.com
21 Aug 2012 • by Natalie Aster
LONDON – With the increasing knowledge of human DNA, a new segment called personalized medicines has emerged in the healthcare industry, which includes therapeutics, diagnostics, and theranostics tailored towards the treatment or prevention of disease. Even though personalized medicines are in their nascent stages, it is expected to transform the biopharmaceutical and molecular diagnostics markets in the coming years.
New study “Personalized Medicine - A Global Market Overview” developed by Industry Experts reviews, analyzes and projects the personalized medicine market globally and across individual regions, including the US, Europe and ROW, with the regional markets further analyzed for 23 independent countries. The study includes recent and current trends related to technology and the market along with the key industry developments, and presents profiles of 56 key global players and 77 major players across the United States – 45; Europe – 24; and ROW – 8. A global listing of 395 companies engaged in personalized medicine, including their addresses, contact numbers and the website addresses, is also provided.
Personalized medicine product types mentioned include: targeted biologics, proteomics & genomics, genetically modified (GM) products, wellness & disease management, other molecular diagnostics and self/other diagnostics.
Personalized medicine application technologies covered are: pharmacogenomics, point-of-care testing, stem cell therapy, pharmacoproteomics, pharmacogenetics and other technologies.
Personalized Medicine - A Global Market Overview
Published: August, 2012
Price: US$ 3.600,00
More new studies by the publisher can be found at Industry Experts page.